A qualitative descriptive study was conducted to learn about nurses’ experiences administering care to pediatric patients with neuroblastoma who are receiving radioactive therapy.
Adding interferon alfa to treatment with temozolomide and radiotherapy prolongs survival in patients with newly diagnosed, high grade glioma, a phase 3 trial suggests.
Survival outcomes improved with extent of tumor resection ≥75 percent for patients with grade 2 glioma.
In preclinical studies, WP1122 has shown to increase cellular uptake of 2-DG, increase drug half-life, and increase the ability to cross the blood brain barrier.
Research suggests hippocampal-sparing radiation may be feasible for pediatric patients with medulloblastoma because the risk of peri‐hippocampal recurrence is low.
Results of a 16-week project to improve adherence to guidelines for prophylactic AED use in seizure-naive patients with newly diagnosed brain tumor.
Catheter pump system capable of CED of topotecan well tolerated and active in recurrent glioblastoma.
Among glioblastoma patients, women may derive more benefit from immunotherapy than men, research suggests.
Researchers say they have identified a molecular signature that can be used to predict outcomes of regorafenib treatment in patients with recurrent glioblastoma.
Children and adolescents with medulloblastoma frequently suffer from neuroophthalmological sequelae, a single-center study suggests.
